Abivax S.A. ( ABVX) - Key Metrics
ABVX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.47 | -$0.65 | -$0.65 |
| 2025Q4 | $0 | -$4.14 | -$1.03 | -$1.03 |
| 2025Q2 | $0 | -$0.76 | -$0.53 | -$0.53 |
| 2024Q4 | $0 | -$0.83 | -$0.53 | -$0.53 |
| 2024Q2 | $0 | -$0.62 | -$0.80 | -$0.80 |
ABVX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.84 |
| 2025Q4 | 0% | -13.66 |
| 2025Q2 | 0% | -1.02 |
| 2024Q4 | 0% | -1.18 |
| 2024Q2 | 0% | -4.86 |
ABVX
Price: $85.95
52 week price:
Earnings Per Share: -6.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.4 billion